Open Access

[Corrigendum] In vitro and in vivo activities of an antitumor peptide HM-3: A special dose-efficacy relationship on an HCT‑116 xenograft model in nude mice

  • Authors:
    • Sitelbanat Yassin
    • Jialiang Hu
    • Hanmei Xu
    • Ce Li
    • Sarra Setrerrahmane
  • View Affiliations

  • Published online on: February 13, 2020     https://doi.org/10.3892/or.2020.7503
  • Pages: 1349-1349
  • Copyright : © Yassin et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

After the publication of the article, the authors have realized that Figs. 3 and 7 in their paper were published with errors; in the first instance, regarding Fig. 3, panels ‘C’ and ‘D’ contained partially overlapping data and were derived from the same original source, where these images were intended to show the effect of 2 ng/ml sunitinib and 2 µg/ml HM‑3, respectively, on cell migration. Likewise, in Fig. 7, panels ‘C’ and ‘D’ also contained partially overlapping data derived from the same original source, even though these images were intended to show representative images for sections of tumor tissue from the HM‑3 (3 mg/kg) and HM‑3 (48 mg/kg) treatment groups. These errors arose inadvertently, as a consequence of the authors' mishandling of their data. The revised versions of Figs. 3 and 7, featuring the corrected data panels for panels ‘C’ and ‘D’ in both Figures, are shown opposite. The revised data shown for these Figures do not affect the overall conclusions reported in the paper. The authors apologize to the Editor of Oncology Reports and to the readership for any inconvenience caused. [the original article was published in Oncology Reports 36: 2951‑2959, 2016; DOI: 10.3892/or.2016.5077].

Related Articles

Journal Cover

April 2020
Volume 43 Issue 4

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
APA
Yassin, S., Hu, J., Xu, H., Li, C., & Setrerrahmane, S. (2020). [Corrigendum] In vitro and in vivo activities of an antitumor peptide HM-3: A special dose-efficacy relationship on an HCT‑116 xenograft model in nude mice. Oncology Reports, 43, 1349-1349. https://doi.org/10.3892/or.2020.7503
MLA
Yassin, S., Hu, J., Xu, H., Li, C., Setrerrahmane, S."[Corrigendum] In vitro and in vivo activities of an antitumor peptide HM-3: A special dose-efficacy relationship on an HCT‑116 xenograft model in nude mice". Oncology Reports 43.4 (2020): 1349-1349.
Chicago
Yassin, S., Hu, J., Xu, H., Li, C., Setrerrahmane, S."[Corrigendum] In vitro and in vivo activities of an antitumor peptide HM-3: A special dose-efficacy relationship on an HCT‑116 xenograft model in nude mice". Oncology Reports 43, no. 4 (2020): 1349-1349. https://doi.org/10.3892/or.2020.7503